Preferential recruitment of ataxin-3 independent of expanded polyglutamine: an immunohistochemical study on Marinesco bodies

Fujigasaki, H.; Uchihara, T.; Takahashi, J.; Matsushita, H.; Nakamura, A.; Koyano, S.; Iwabuchi, K.; Hirai, S.; Mizusawa, H.
October 2001
Journal of Neurology, Neurosurgery & Psychiatry;Oct2001, p518
Academic Journal
No abstract available.


Related Articles

  • Non-expanded polyglutamine proteins in intranuclear inclusions of hereditary ataxias — triple-labeling immunofluorescence study. Uchihara, Toshiki; Fujigasaki, Hiroto; Koyano, Shigeru; Nakamura, Ayako; Yagishita, Saburo; Iwabuchi, Kiyoshi // Acta Neuropathologica;Aug2001, Vol. 102 Issue 2, p149 

    Neuronal intranuclear inclusions (NIIs) found in CAG/polyglutamine-expansion disorders contain both expanded polyglutamine and the gene product without the CAG repeat. The gene product containing expanded polyglutamine has, therefore, been considered to be a major component of NIIs. In this...

  • 14-3-3 Proteins and Spinocerebellar Ataxia Type 1: from Molecular Interaction to Human Neuropathology. Umahara, Takahiko; Uchihara, Toshiki // Cerebellum;Jun2010, Vol. 9 Issue 2, p183 

    This mini-review focuses on the possible relevance of 14-3-3 proteins in spinocerebellar ataxia type 1 (SCA1). 14-3-3 proteins are mainly localized in the synapses and neuronal cytoplasm, and seven isoforms have been identified in mammals. This family of proteins was initially identified as...

  • Spinocerebellar ataxia 2 (SCA2). Lastres-Becker, Isabel; R�b, Udo; Auburger, Georg // Cerebellum;Jun2008, Vol. 7 Issue 2, p115 

    Spinocerebellar ataxia type 2 (SCA2) is an autosomal dominantly inherited, neurodegenerative disease. It can manifest either with a cerebellar syndrome or as Parkinson�s syndrome, while later stages involve mainly brainstem, spinal cord and thalamus. This particular atrophy pattern...

  • Expression of ataxin-7 in CNS and non-CNS tissue of normal and SCA7 individuals. Jonasson, Jenni; Ström, Anna-Lena; Hart, Patricia; Brännström, Thomas; Forsgren, Lars; Holmberg, Monica // Acta Neuropathologica;Jul2002, Vol. 104 Issue 1, p29 

    Spinocerebellar ataxia type 7 (SCA7) is a neurodegenerative disorder primarily affecting the cerebellum, brain stem and retina. The disease is caused by an expanded polyglutamine tract in the protein ataxin-7. In this study we analyzed the expression pattern of ataxin-7 in CNS and non-CNS tissue...

  • Ubiquitin ligase ITCH recruitment suppresses the aggregation and cellular toxicity of cytoplasmic misfolded proteins. Chhangani, Deepak; Upadhyay, Arun; Amanullah, Ayeman; Joshi, Vibhuti; Mishra, Amit // Scientific Reports;5/30/2014, p1 

    The protein quality control (QC) system protects cells against cellular toxicity induced by misfolded proteins and maintains overall cellular fitness. Inefficient clearance of or failure to degrade damaged proteins causes several diseases, especially age-linked neurodegenerative disorders....

  • Conformational Behavior and Aggregation of Ataxin-3 in SDS. Saunders, Helen M.; Hughes, Victoria A.; Cappai, Roberto; Bottomley, Stephen P. // PLoS ONE;Jul2013, Vol. 8 Issue 7, p1 

    Spinocerebellar ataxia type 3 (SCA3) is one of nine polyglutamine (polyQ) diseases all characterized by the presence of intraneuronal inclusions that contain aggregated protein. Aggregation of ataxin-3, the causative protein of SCA3, has been well characterized in vitro, with both pathogenic and...

  • Intranuclear ataxin1 inclusions contain both fast-and slow-exchange components. Stenoien, David L.; Mielke, Marilyn; Mancini, Michael A. // Nature Cell Biology;Oct2002, Vol. 4 Issue 10, p806 

    A hallmark of neurodegenerative diseases caused by polyglutamine expansion is the abnormal accumulation of mutant proteins into ubiquitin-positive inclusions. The local build-up of these ubiquitinated proteins suggests that the proteasome machinery inadequately clears misfolded proteins,...

  • Calpain inhibition reduces ataxin-3 cleavage alleviating neuropathology and motor impairments in mouse models of Machado–Joseph disease. Simões, Ana Teresa; Gonçalves, Nélio; Nobre, Rui Jorge; Duarte, Carlos Bandeira; Pereira de Almeida, Luís // Human Molecular Genetics;Sep2014, Vol. 23 Issue 18, p4932 

    Machado–Joseph Disease (MJD) is the most prevalent autosomal dominantly inherited cerebellar ataxia. It is caused by an expanded CAG repeat in the ATXN3 gene, which translates into a polyglutamine tract within the ataxin-3 protein. Present treatments are symptomatic and do not prevent...

  • Altered Expression of Carbonic Anhydrase-Related Protein XI in Neuronal Cells Expressing Mutant Ataxin-3. Hsieh, Mingli; Chang, Wei-Hsiu; Hsu, Chi-Fu; Nishimori, Isao; Kuo, Cheng-Liang; Minakuchi, Tomoko // Cerebellum;Jun2013, Vol. 12 Issue 3, p338 

    Spinocerebellar ataxia type 3/Machado-Joseph disease (SCA3/MJD) is a late-onset neurodegenerative disorder caused by the expansion of a polyglutamine tract within the gene product, ataxin-3. Microarray analysis revealed a dramatic differential expression of carbonic anhydrase-related protein XI...

  • Calpain-mediated ataxin-3 cleavage in the molecular pathogenesis of spinocerebellar ataxia type 3 (SCA3). Hübener, Jeannette; Weber, Jonasz Jeremiasz; Richter, Claudia; Honold, Lisa; Weiss, Andreas; Murad, Fabronia; Breuer, Peter; Wüllner, Ullrich; Bellstedt, Peter; Paquet-Durand, Francois; Takano, Jiro; Saido, Takaomi C.; Riess, Olaf; Nguyen, Huu Phuc // Human Molecular Genetics;Feb2013, Vol. 22 Issue 3, p508 

    Spinocerebellar ataxia type 3 (SCA3) is pathologically characterized by the formation of intranuclear aggregates which contain ataxin-3, the mutated protein in SCA3, in a specific subtype of neurons. It has been proposed that ataxin-3 is cleaved by proteolytic enzymes, in particular by calpains...


Read the Article


Sign out of this library

Other Topics